Gerald P Linette

10PUBLICATIONS
116CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Micro-manipulationGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 27, 2026
Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPV+ tumors.

Ying Liu, Zhiheng Zhang, Yanshan Tao

|Jul 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

|Jun 13, 2024
Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors.

Ju-Fang Chang, Nils Wellhausen, Nils W Engel

|Jan 24, 2024
Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations.

Gerald P Linette, Adham S Bear, Beatriz M Carreno

|Jun 28, 2023
Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T Cells Administered Intravenously in Patients with Melanoma and Breast Carcinoma.

Payal D Shah, Alexander C Huang, Xiaowei Xu

|Nov 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Alfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya

Pageof 2

Frequent Collaborators

6 joint publications

Beatriz M Carreno

3 joint publications

Adham S Bear

3 joint publications

Carl H June

2 joint publications

Joseph A Fraietta